American Journal of Translational Research

metrics 2024

Elevating Translational Research for Better Health

Introduction

The American Journal of Translational Research is a pivotal publication in the fields of Biochemistry, Genetics, and Molecular Biology, dedicated to advancing the understanding of translational science and its applications in clinical settings. Published by E-CENTURY PUBLISHING CORP, this journal, under ISSN 1943-8141, fosters scholarly exchange by publishing original research articles, reviews, and clinical studies that bridge the gap between laboratory discoveries and actual medical practice. Although its coverage in Scopus has been discontinued, the journal has previously held respectable rankings, including a 64th percentile in Clinical Biochemistry and 52nd in both Molecular Medicine and Cancer Research, indicating its influence and relevance in the scientific community. With its formal objective of disseminating significant findings that inform clinical practices, the journal remains a valuable resource for researchers, healthcare professionals, and students eager to stay at the forefront of translational research advancements.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor1.70
Journal Impact Factor (5 years)2.30
H-Index-
Journal IF Without Self1.70
Eigen Factor0.01
Normal Eigen Factor3.20
Influence0.45
Immediacy Index0.20
Cited Half Life4.30
Citing Half Life5.20
JCI0.44
Total Documents-
WOS Total Citations12773
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank1.03
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

Scopus

Clinical Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #41/113
Percentile 63.72
Quartile Q2
Molecular Medicine in Biochemistry, Genetics and Molecular Biology
Rank #79/167
Percentile 52.69
Quartile Q2
Cancer Research in Biochemistry, Genetics and Molecular Biology
Rank #98/207
Percentile 52.66
Quartile Q2

IF (Web Of Science)

MEDICINE, RESEARCH & EXPERIMENTAL
Rank 135/189
Percentile 28.80
Quartile Q3
ONCOLOGY
Rank 250/322
Percentile 22.50
Quartile Q4

JCI (Web Of Science)

MEDICINE, RESEARCH & EXPERIMENTAL
Rank 131/189
Percentile 30.69
Quartile Q3
ONCOLOGY
Rank 229/322
Percentile 28.88
Quartile Q3

Quartile History

Similar Journals

Translational Medicine at UniSa

Where Laboratory Insights Meet Clinical Excellence
Publisher: UNIV STUDI SALERNOISSN: 2239-9747Frequency: 3 issues/year

Translational Medicine at UniSa, published by the esteemed UNIV STUDI SALERNO, serves as a pivotal platform for disseminating innovative research in the field of translational medicine. With its ISSN 2239-9747, this journal aims to bridge the gap between laboratory research and clinical application, facilitating the transformation of scientific findings into practical healthcare solutions. Committed to fostering collaboration among researchers, clinicians, and educators, Translational Medicine at UniSa aspires to enhance evidence-based medicine practices and improve patient outcomes. Although the journal is not currently open access, its rigorous peer-review process ensures that only high-quality research reaches its audience. As an influential publication in the realm of medical research, it is essential for professionals, researchers, and students seeking to stay at the forefront of advancements in translational medicine.

Experimental and Therapeutic Medicine

Exploring groundbreaking methodologies in experimental medicine.
Publisher: SPANDIDOS PUBL LTDISSN: 1792-0981Frequency: 12 issues/year

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

Byulleten Sibirskoy Meditsiny

Fostering Knowledge Exchange in the Heart of Siberia
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

JOURNAL OF INVESTIGATIVE MEDICINE

Exploring Breakthroughs in Medical Research
Publisher: SAGE PUBLICATIONS LTDISSN: 1081-5589Frequency: 8 issues/year

JOURNAL OF INVESTIGATIVE MEDICINE, published by SAGE PUBLICATIONS LTD, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and medicine. With an impressive Scopus ranking placing it in the 64th percentile, the journal consistently showcases significant research, fostering advancements in our understanding of complex biological processes. Spanning from 1994 to 2024, this quarterly publication is recognized as Q2 in both Biochemistry, Genetics and Molecular Biology and Medicine categories, indicating its relevance and quality in these disciplines. While the journal does not offer open access, it provides robust insights that assist in shaping current academic and clinical practices. Located in the United States, the JOURNAL OF INVESTIGATIVE MEDICINE is essential for scholars aiming to stay at the forefront of investigative medical research.

Science Translational Medicine

Empowering Progress in Translational Medicine.
Publisher: AMER ASSOC ADVANCEMENT SCIENCEISSN: 1946-6234Frequency: 51 issues/year

Science Translational Medicine is a premier journal published by the American Association for the Advancement of Science, dedicated to bridging the gap between laboratory discovery and clinical application. With an impressive impact factor and a Q1 categorization in the field of Medicine, it is recognized as one of the leading journals, ranking 11 out of 636 in general medicine according to Scopus, placing it in the top 2% of its category. Since its inception in 2009, the journal has been at the forefront of innovative research, presenting high-quality studies that translate scientific advancements into tangible medical solutions. Researchers, professionals, and students alike will find its rich content invaluable for staying informed on cutting-edge developments in the field. The journal's commitment to accessibility ensures that the latest findings and insights are available to a global audience, fostering collaboration and scientific progress.

CTS-Clinical and Translational Science

Bridging research and application for a healthier tomorrow.
Publisher: WILEYISSN: 1752-8054Frequency: 12 issues/year

CTS-Clinical and Translational Science, published by WILEY, is a leading journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, medicine, neuroscience, and pharmacology. With its Open Access policy since 2016, the journal ensures that groundbreaking research is readily available to a global audience, fostering collaboration and innovation. Based in the United Kingdom, CTS boasts a commendable Impact Factor that reflects its esteemed status, ranking in the Q1 category for various disciplines, including Pharmacology, Toxicology, and Pharmaceutics, and Biochemistry, Genetics and Molecular Biology. With its convergence years from 2008 to 2024, the journal remains at the forefront of scientific discovery, actively promoting novel research that bridges the gap between laboratory results and clinical application. Researchers, professionals, and students alike will find CTS an invaluable resource for the latest insights and advancements in clinical and translational science.

ARCHIVES OF MEDICAL RESEARCH

Elevating clinical practices through impactful research.
Publisher: ELSEVIER SCIENCE INCISSN: 0188-4409Frequency: 8 issues/year

Archives of Medical Research is a prestigious scholarly journal dedicated to advancing the field of medicine through the dissemination of high-quality research findings. Published by Elsevier Science Inc., this esteemed journal has garnered significant recognition, boasting a remarkable impact factor and ranking in the top quartile (Q1) of its category, specifically in General Medicine with a Scopus rank of #30 out of 636 journals, placing it in the 95th percentile. Since its inception in 1992, Archives of Medical Research has served as a critical platform for researchers and professionals to share innovative insights and empirical studies that address pressing medical issues and enhance clinical practices. The journal welcomes a range of submissions, ensuring a diverse array of topics that reflect the latest trends and developments in medicine. As the journal continues to push the boundaries of medical research until at least 2025, it remains an essential resource for students, academics, and healthcare professionals striving to make a meaningful impact in the medical community.

CLINICAL AND EXPERIMENTAL MEDICINE

Bridging the Gap Between Research and Practice
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 1591-8890Frequency: 4 issues/year

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

ANNALS OF CLINICAL AND LABORATORY SCIENCE

Innovating Diagnostic Practices Through Peer Review
Publisher: ASSOC CLINICAL SCIENTISTSISSN: 0091-7370Frequency: 6 issues/year

ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

Northern Clinics of Istanbul

Advancing medical knowledge for a healthier tomorrow.
Publisher: KARE PUBLISSN: 2148-4902Frequency: 6 issues/year

Northern Clinics of Istanbul is an esteemed open-access journal dedicated to advancing knowledge within the field of medicine, specifically focusing on miscellaneous areas of general medicine. Published by KARE PUBL since 2014, it provides a vital platform for researchers, healthcare professionals, and students to share innovative findings and foster academic dialogue. With its ISSN 2148-4902 and E-ISSN 2536-4553, the journal has garnered attention in the academic community, earning a reputable Q4 quartile ranking in the category of Medicine (Miscellaneous) for the year 2023 and a Scopus rank of #497 out of 636. Based in Istanbul, Turkey, the journal is committed to accessibility and relevance, making significant contributions to the global medical discourse. Northern Clinics of Istanbul aims to serve as an interdisciplinary hub for innovative research, promoting the dissemination of knowledge and enhancing collaborative efforts among scholars. Join us in exploring the latest insights that are shaping healthcare today.